Covered recipient · General Payments record
JANICE LEE DAVOLIO
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$3,610.70
- Reported across 174 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $740.88 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $336.43 | 18 |
| PFIZER INC. | $78.82 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $59.85 | 2 |
| Dermavant Sciences, Inc. | $49.66 | 2 |
| GENZYME CORPORATION | $42.52 | 1 |
| Arcutis Biotherapeutics, Inc. | $42.27 | 2 |
| UCB, Inc. | $30.88 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.22 | 1 |
| Galderma Laboratories, L.P. | $24.93 | 1 |
| Lilly USA, LLC | $24.32 | 1 |
| ORGANOGENESIS INC. | $21.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.52 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610670 | CMS |
| ABBVIE INC. | $18.75 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610672 | CMS |
| ABBVIE INC. | $24.34 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610674 | CMS |
| ABBVIE INC. | $11.34 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610676 | CMS |
| ABBVIE INC. | $22.87 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610678 | CMS |
| ABBVIE INC. | $14.20 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610680 | CMS |
| ABBVIE INC. | $28.73 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610682 | CMS |
| ABBVIE INC. | $3.17 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610684 | CMS |
| ABBVIE INC. | $27.99 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610686 | CMS |
| ABBVIE INC. | $16.00 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610688 | CMS |
| ABBVIE INC. | $33.07 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610690 | CMS |
| ABBVIE INC. | $28.11 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610692 | CMS |
| ABBVIE INC. | $5.75 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610694 | CMS |
| ABBVIE INC. | $5.20 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610696 | CMS |
| ABBVIE INC. | $21.59 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610698 | CMS |
| ABBVIE INC. | $9.77 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610700 | CMS |
| ABBVIE INC. | $28.08 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610702 | CMS |
| ABBVIE INC. | $31.95 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103610704 | CMS |
| Arcutis Biotherapeutics, Inc. | $18.40 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121051649 | CMS |
| Arcutis Biotherapeutics, Inc. | $23.87 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121051651 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $29.22 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118256482 | CMS |
| Dermavant Sciences, Inc. | $28.35 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127860852 | CMS |
| Dermavant Sciences, Inc. | $21.31 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127860854 | CMS |
| Galderma Laboratories, L.P. | $24.93 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145293411 | CMS |
| GENZYME CORPORATION | $42.52 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139630325 | CMS |
| Lilly USA, LLC | $24.32 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135026930 | CMS |
| Novartis Pharmaceuticals Corporation | $32.13 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086878401 | CMS |
| Novartis Pharmaceuticals Corporation | $27.72 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086878407 | CMS |
| Organogenesis Inc. | $21.98 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145424992 | CMS |
| PFIZER INC. | $17.12 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131344002 | CMS |
| PFIZER INC. | $14.61 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131776513 | CMS |
| PFIZER INC. | $16.00 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131944846 | CMS |
| PFIZER INC. | $14.22 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131140169 | CMS |
| PFIZER INC. | $16.87 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131201006 | CMS |
| UCB, Inc. | $30.88 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143040771 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.